AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 85 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $85,000 | +3.7% | 36,787 | +243.7% | 0.00% | – |
Q3 2019 | $82,000 | -42.7% | 10,704 | -48.9% | 0.00% | – |
Q2 2019 | $143,000 | -37.3% | 20,947 | -26.0% | 0.00% | – |
Q1 2019 | $228,000 | +7.5% | 28,297 | 0.0% | 0.00% | – |
Q4 2018 | $212,000 | -21.8% | 28,297 | 0.0% | 0.00% | – |
Q3 2018 | $271,000 | +28.4% | 28,297 | +42.0% | 0.00% | – |
Q2 2018 | $211,000 | – | 19,921 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Yu Fan | 112,044 | $258,000 | 3.49% |
Aisling Capital Management LP | 1,691,151 | $3,890,000 | 2.10% |
Sio Capital Management, LLC | 871,101 | $2,004,000 | 0.66% |
Bain Capital Life Sciences Investors, LLC | 2,847,689 | $6,550,000 | 0.64% |
Samsara BioCapital, LLC | 883,720 | $2,033,000 | 0.51% |
Ghost Tree Capital, LLC | 686,599 | $1,579,000 | 0.34% |
Nantahala Capital Management | 3,200,593 | $7,361,000 | 0.33% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | 245,678 | $565,000 | 0.29% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,059,894 | $9,338,000 | 0.28% |
Lion Point Capital, LP | 300,000 | $690,000 | 0.16% |